Provention Bio
PRVB
#4383
Rank
NZ$4.13 B
Marketcap
NZ$43.45
Share price
0.00%
Change (1 day)
511.22%
Change (1 year)

Operating Margin for Provention Bio (PRVB)

Operating Margin as of January 2026 (TTM): -984.54%

According to Provention Bio's latest financial reports and stock price the company's current Operating Margin is -984.54%. At the end of 2022 the company had an Operating Margin of -984.54%.

Operating Margin history for Provention Bio from 2022 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2022-984.54%-88.1%
2021-8,274.70%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novocure
NVCR
-19.77%-97.99% Jersey
Novavax
NVAX
-25.89%-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-1,726.38% 75.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-129.00%-86.90%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.